Skip to main content
Log in

NMDA channel blockers: memantine and amino-aklylcyclohexanes –In vivo characterization

  • Review Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Summary.

The previous overviews provided the basis for better therapeutic efficacy/tolerability of low to moderate affinity NMDA channel blockers. This prediction finds support in in vitro studies comparing protective and plasticity impairing effects (therapeutic vs. side-effect) of memantine and (+)MK-801. In fact it turned out that memantine had a far better therapeutic index. But can it be confirmed in the in vivo situation?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received August 31, 1999 Accepted September 20, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danysz, W., Parsons, C. & Quack, G. NMDA channel blockers: memantine and amino-aklylcyclohexanes –In vivo characterization. Amino Acids 19, 167–172 (2000). https://doi.org/10.1007/s007260070045

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007260070045

Navigation